Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.
about
Evidence for selection at HIV host susceptibility genes in a West Central African human populationHuman immunodeficiency virus vaccine an update.Variations in CCL3L gene cluster sequence and non-specific gene copy numbers.CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis.Experimental aspects of copy number variant assays at CCL3L1Accuracy and differential bias in copy number measurement of CCL3L1 in association studies with three auto-immune disordersCombinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children.Genetics of Sub-Saharan African Human Population: Implications for HIV/AIDS, Tuberculosis, and MalariaHost genomic HIV restriction factors modulate the response to dendritic cell-based treatment against HIV-1Thirty years on: HIV receptor gymnastics and the prevention of infectionPerceptions of genetic testing and genomic medicine among drug users.Accurate measurement of gene copy number for human alpha-defensin DEFA1A3.CCL3L1 gene copy number in individuals with and without HIV-associated neurocognitive disorderCopy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease.Correlating multiallelic copy number polymorphisms with disease susceptibility.Functional effects of CCL3L1 copy number.Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3.
P2860
Q28710092-38008B40-E712-40FF-A4F5-1EAC6EE15085Q30432382-2C293AB9-D3FF-4C97-AA5E-698EF2482660Q33541256-4A3300DE-9345-4331-BA53-64D6884D4384Q33669282-79B646ED-6C4A-4B66-9576-9A55AB1429FCQ33864642-D58FE354-21DF-46AE-8299-90BCB86C7641Q33996098-E648E3E6-54E3-4226-916D-E1321F9FBB6EQ34091158-6A42DED5-659C-4D7E-BA34-0F8750726B43Q34118827-EE825767-DE4E-429E-A2CB-DB85FD6ABC2CQ34290751-295C67CA-AADE-4DE8-B0E5-385683837819Q34732816-8F2DFB85-C5AE-4803-8242-148E59DD06ABQ34772602-6D229732-BCC4-4E7B-ADA1-645D65B7A11FQ35020478-E8ED7AA5-6DCB-48B1-A5B9-6C4748BE4F32Q36956617-C6CC8AC9-0507-464C-836E-A3DF212C1DFFQ37775691-E145586F-FE99-44B0-860A-FA2EFB1B0960Q38029978-8AAF90E1-C052-4599-962B-50D9E906EEF9Q42258047-56B642E4-128D-40E4-8A36-4EA6EBFA0D54Q53332303-A8513878-C062-4653-986F-7BB030671002
P2860
Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Role of CCL3L1-CCR5 genotypes ...... valuation of vaccine efficacy.
@ast
Role of CCL3L1-CCR5 genotypes ...... valuation of vaccine efficacy.
@en
type
label
Role of CCL3L1-CCR5 genotypes ...... valuation of vaccine efficacy.
@ast
Role of CCL3L1-CCR5 genotypes ...... valuation of vaccine efficacy.
@en
prefLabel
Role of CCL3L1-CCR5 genotypes ...... valuation of vaccine efficacy.
@ast
Role of CCL3L1-CCR5 genotypes ...... valuation of vaccine efficacy.
@en
P2093
P2860
P50
P1433
P1476
Role of CCL3L1-CCR5 genotypes ...... valuation of vaccine efficacy.
@en
P2093
George Crawford
Hemant Kulkarni
Matthew J Dolan
Robert A Clark
Sunil K Ahuja
P2860
P356
10.1371/JOURNAL.PONE.0003671
P407
P577
2008-11-07T00:00:00Z